CEL Celadon Pharmaceuticals Plc

    RNS Number : 8702C
  Celsis International PLC
  05 September 2008
   


 For filings with the FSA include the annex
 For filings with issuer exclude the annex 

 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying issuer   Celsis International
 of existing shares to which voting rights are                         Plc
 attached:


 2. Reason for notification (yes/no)
                                                                               X
 An acquisition or disposal of voting rights

 An acquisition or disposal of financial instruments which may result in the
 acquisition of shares already issued to which voting rights are attached 

 An event changing the breakdown of voting rights

 Other (please specify):______________

 3. Full name of person(s)               Barclays PLC
 subject to notification
 obligation:
                                      Barclays Global
 4. Full name of shareholder(s)         Investors Ltd
 (if different from 3):                 Barclays Life
                                     Assurance Co Ltd
                                             Barclays
                                     Stockbrokers Ltd
                                            03-Sep-08
 5. Date of transaction (and
 date on which the threshold is
 crossed or reached if
 different):
                                            04-Sep-08
 6. Date on which issuer
 notified:
                                             7% to 6%
 7. Threshold(s) that is/are
 crossed or reached:


 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares  Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN  transaction
 code
                       Number of shares      Number of voting      Number of shares  Number of voting        Percentage of voting
                                             rights                                  rights                  rights

                                                                                     Direct  Indirect        Direct       Indirect
                                  1,619,344             1,619,344         1,394,164       0       1,394,164         0.00      6.36
 GB00B0CD5F69



 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)




 Total (A+B)

 Number of voting rights  Percentage of voting rights
 1,394,164                                       6.36



 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 Barclays Global Investors Ltd
 Barclays Life Assurance Co Ltd
 Barclays Stockbrokers Ltd

 Proxy Voting:

 10. Name of proxy holder:                                         
                                                                   
 11. Number of voting rights proxy holder will cease to hold:      
                                                                   
 12. Date on which proxy holder will cease to hold voting rights:  
                                                                   

 13. Additional information:

 14 Contact name:                 Geoff Smith

 15. Contact telephone number:  020 7116 2913


    For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUVSORWKRKRAR

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024